新华联
(000620)
| 流通市值：93.26亿 | | | 总市值：132.12亿 |
| 流通股本：41.45亿 | | | 总股本：58.72亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 819,995,996.8 | 841,388,218.83 | 747,411,366.65 | 1,005,969,185.89 |
| 拆出资金 | - | 0 | - | 0 |
| 衍生金融资产 | - | 0 | - | 0 |
| 应收票据及应收账款 | 289,036,495.85 | 258,978,931.26 | 231,771,455.29 | 275,677,444.06 |
| 其中：应收票据 | - | 0 | - | 0 |
| 应收账款 | 289,036,495.85 | 258,978,931.26 | 231,771,455.29 | 275,677,444.06 |
| 预付款项 | 311,821,400.89 | 369,400,176.91 | 412,136,772.26 | 418,977,961.23 |
| 应收保费 | - | 0 | - | 0 |
| 应收分保账款 | - | 0 | - | 0 |
| 应收分保合同准备金 | - | 0 | - | 0 |
| 其他应收款合计 | 293,798,310.35 | 302,236,167.21 | 334,553,135.12 | 329,984,857.57 |
| 其中:应收利息 | - | 0 | - | 0 |
| 应收股利 | 146,234.98 | 146,234.98 | 146,234.98 | 146,234.98 |
| 买入返售金融资产 | - | 0 | - | 0 |
| 存货 | 6,339,404,131.76 | 6,455,370,842.61 | 6,873,750,574.54 | 7,191,881,281.47 |
| 合同资产 | 1,427,861.88 | 1,427,861.88 | 1,427,861.88 | 1,505,086.5 |
| 一年内到期的非流动资产 | - | - | - | 0 |
| 其他流动资产 | 529,929,150.57 | 529,377,155.69 | 535,286,493.89 | 554,546,265.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 8,692,741,904.97 | 8,865,507,911.26 | 9,243,666,204.37 | 9,885,870,626.81 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | - | 0 |
| 长期股权投资 | 3,374,491.07 | 3,273,934.89 | 2,873,220.53 | 2,273,375.28 |
| 其他权益工具投资 | - | - | - | 0 |
| 投资性房地产 | - | - | - | 0 |
| 固定资产 | 3,617,702,624.57 | 3,614,631,022.31 | 3,663,282,932.72 | 3,708,857,386.53 |
| 在建工程 | 593,173,021.3 | 592,917,778.42 | 315,914,220.13 | 315,947,371.09 |
| 生产性生物资产 | - | 0 | - | 0 |
| 油气资产 | - | 0 | - | 0 |
| 无形资产 | 483,327,200.36 | 489,866,594.67 | 563,269,979.99 | 581,867,592.68 |
| 开发支出 | - | - | - | 0 |
| 商誉 | 117,618,206.15 | 117,618,206.15 | 117,618,206.15 | 117,618,206.15 |
| 长期待摊费用 | 29,985,725.79 | 32,012,564.5 | 34,118,975.81 | 36,053,561.49 |
| 递延所得税资产 | 140,039,961.21 | 129,002,431.18 | 133,790,956.3 | 129,705,052.81 |
| 其他非流动资产 | - | 0 | - | 0 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,985,221,230.45 | 4,979,322,532.12 | 4,830,868,491.63 | 4,892,322,546.03 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 13,677,963,135.42 | 13,844,830,443.38 | 14,074,534,696 | 14,778,193,172.84 |
| 流动负债: | | | | |
| 短期借款 | 51,240,000 | 51,440,000 | 50,000,000 | 51,050,000 |
| 吸收存款及同业存放 | - | 0 | - | 0 |
| 交易性金融负债 | - | 0 | - | 0 |
| 衍生金融负债 | - | 0 | - | 0 |
| 应付票据及应付账款 | 1,860,267,788.81 | 1,944,742,585.59 | 2,016,125,576.17 | 2,136,716,582.15 |
| 其中：应付票据 | - | 0 | - | 0 |
| 应付账款 | 1,860,267,788.81 | 1,944,742,585.59 | 2,016,125,576.17 | 2,136,716,582.15 |
| 预收款项 | 700,618.16 | 702,117.37 | 1,745,572.06 | 1,538,492.79 |
| 合同负债 | 1,856,878,055.14 | 2,054,408,680.19 | 2,288,841,251.49 | 2,688,280,291.28 |
| 卖出回购金融资产款 | - | 0 | - | 0 |
| 应付手续费及佣金 | - | 0 | - | 0 |
| 应付职工薪酬 | 79,856,424.01 | 71,088,974.68 | 71,038,239.74 | 132,191,525.72 |
| 应交税费 | 343,125,247.08 | 311,319,995.15 | 270,552,747.55 | 216,377,276.42 |
| 其他应付款合计 | 495,734,928 | 505,591,993.7 | 562,603,319.66 | 693,886,147.77 |
| 其中:应付利息 | - | 0 | - | 0 |
| 应付股利 | 0 | 2,274,830.38 | 3,274,830.38 | 3,282,793.26 |
| 代理买卖证券款 | - | 0 | - | 0 |
| 一年内到期的非流动负债 | 695,459,479.48 | 666,676,909.1 | 643,608,909.53 | 620,753,425.67 |
| 其他流动负债 | 491,334,155.3 | 508,474,703.7 | 490,864,474.2 | 554,422,426 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,874,596,695.98 | 6,114,445,959.48 | 6,395,380,090.4 | 7,095,216,167.8 |
| 非流动负债: | | | | |
| 长期借款 | 1,354,468,646.65 | 1,354,468,646.65 | 1,348,574,646.65 | 1,348,574,646.65 |
| 应付债券 | - | 0 | - | 0 |
| 优先股 | - | 0 | - | 0 |
| 永续债 | - | 0 | - | 0 |
| 长期应付款 | 212,318.25 | 212,318.25 | 359,007.98 | 359,007.98 |
| 长期应付职工薪酬 | - | 0 | - | 0 |
| 预计负债 | - | 0 | - | 0 |
| 递延收益 | 357,928,204 | 344,113,440.2 | 328,581,554.77 | 330,367,673.01 |
| 递延所得税负债 | 2,703,694 | 2,703,694 | 19,057,291.1 | 19,294,901.65 |
| 其他非流动负债 | - | 0 | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,715,312,862.9 | 1,701,498,099.1 | 1,696,572,500.5 | 1,698,596,229.29 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 7,589,909,558.88 | 7,815,944,058.58 | 8,091,952,590.9 | 8,793,812,397.09 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,658,877,225 | 1,658,877,225 | 1,658,877,225 | 1,658,877,225 |
| 其他权益工具 | - | 0 | - | 0 |
| 优先股 | - | 0 | - | 0 |
| 永续债 | - | 0 | - | 0 |
| 资本公积 | 6,630,488,954.23 | 6,600,415,540.29 | 6,594,221,069.64 | 6,595,177,200.33 |
| 其他综合收益 | 86,642,207.46 | 86,506,567.68 | 73,908,504.15 | 82,447,079.28 |
| 专项储备 | 573,868 | 573,868 | 573,868 | 0 |
| 盈余公积 | 246,744,097.39 | 246,744,097.39 | 246,744,097.39 | 246,744,097.39 |
| 一般风险准备 | - | 0 | - | 0 |
| 未分配利润 | -3,122,377,091.34 | -3,164,023,554.95 | -3,185,195,598.28 | -3,205,881,246.63 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,500,949,260.74 | 5,429,093,743.41 | 5,389,129,165.9 | 5,377,364,355.37 |
| 少数股东权益 | 587,104,315.8 | 599,792,641.39 | 593,452,939.2 | 607,016,420.38 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,088,053,576.54 | 6,028,886,384.8 | 5,982,582,105.1 | 5,984,380,775.75 |
| 负债和股东权益合计 | 13,677,963,135.42 | 13,844,830,443.38 | 14,074,534,696 | 14,778,193,172.84 |
| 公告日期 | 2024-10-31 | 2024-07-27 | 2024-04-18 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |